摘要
目的了解某肿瘤医院多重耐药菌(MDRO)的分布情况,为医院感染防控提供依据。方法回顾性分析贵州省肿瘤医院2011—2013年临床送检标本中分离的MDRO监测资料。结果 2011—2013年共检出1 165株MDRO,产超广谱β-内酰胺酶(ESBLs)大肠埃希菌检出最多(626株,占53.73%),其次为耐甲氧西林凝固酶阴性葡萄球菌(MRCNS)(209株,占17.94%);各年检出MDRO数量呈递增趋势。MDRO标本来源以痰/咽拭子(346株,占29.70%)、分泌物(322株,27.64%)及尿(227株,19.48%)为主;检出科室主要为重症监护病房(ICU)(210株,占18.03%),其次为泌尿外科(173株,占14.85%)。结论该肿瘤医院患者分离的MDRO主要来源于呼吸道、伤口分泌物及泌尿系统,应加强对高危科室及易感人群的监控,制定有针对性预防控制措施,遏制MDRO的感染和传播。
Objective To understand the distribution of multidrug-resistant organisms(MDROs)in a cancer hospital,and provide basis for the prevention and control of healthcare-associated infection(HAI).Methods Monitored data of MDROs from clinical specimens in Guizhou Cancer Hospital in 2011-2013 were analyzed retrospectively.Results A total of 1 165 MDRO strains were isolated in2011-2013,most of which were extended-spectrum beta-lactamase-producing Escherichia coli(n=626,53.73%),followed by methicillin-resistant coagulase negative staphylococcus(MRCNS,n= 209,17.94%);MDRO detection rate increased year by year.MDROs were mainly isolated from sputum/throat swabs(n=346,29.70%),secretion(n=322,27.64%),and urine(n=227,19.48%);intensive care unit and department of urology were the major departments of emergence of MDROs,accounting for18.03%(n=210)and14.85%(n=173)respectively.Conclusion MDROs in this hospital are mainly isolated from respiratory tract,surgical wound,and urinary system,monitoring of high-risk departments and susceptible population should be strengthened,targeted prevention and control measures should be developed to curb the infection and spread of MDROs.
出处
《中国感染控制杂志》
CAS
北大核心
2016年第1期45-48,共4页
Chinese Journal of Infection Control
关键词
肿瘤医院
多重耐药菌
产超广谱Β-内酰胺酶
医院感染
cancer hospital
multidrug-resistant organism
extended-spectrum beta-lactamase
healthcare-associated infection